Learning Objectives
By the end of this session, the learner will be able to distinguish between Benzodiazepines (BZs) and Barbiturates/Alcohol based on their dose-response curves, mechanisms of action on the 
1. Dose-Dependent CNS Depression
Sedative-hypnotic drugs exhibit a spectrum of CNS depression. The primary clinical difference between drug classes is the “ceiling effect” (or lack thereof).
| CNS State | Description |
|---|---|
| Sedation | Reduction of anxiety and psychomotor performance. |
| Hypnosis | Induction of sleep. |
| Anesthesia | Loss of consciousness and surgical responsiveness. |
| Medullary Depression | Depression of respiratory and vasomotor centers  Death. |
2. Comparison of Drug Classes
The safety profile of these drugs is determined by how their dose-response curve interacts with the medullary depression threshold.
| Drug Class | Curve Characteristic | Safety Profile |
|---|---|---|
| Benzodiazepines (BZs) | Non-linear (Plateaus) | Relatively safe; rarely causes fatal respiratory depression alone. |
| Barbiturates & Alcohol | Linear (No Plateau) | High risk; overdose easily crosses the threshold into Death. |
3. Mechanism at the Receptor
Both classes facilitate the action of GABA, the primary inhibitory neurotransmitter in the CNS, but they do so differently at the Chloride (
| Drug Class | Effect on Channel |
Mnemonic |
|---|---|---|
| Benzodiazepines | Increases the frequency of opening. | Frenetic Benzos |
| Barbiturates | Increases the duration of opening. | Durable Barbs |
Clinical Pearls for Medical Exams:
- The “Add-On” Danger: While BZs are safe alone, combining them with other CNS depressants (Alcohol, Opioids, Barbs) shifts the curve, potentially causing fatal respiratory depression.
- Antidote: Flumazenil is a competitive antagonist for Benzodiazepines, but it does not reverse Barbiturate or Alcohol toxicity.
- Barbiturate Risk: At high doses, barbiturates can act as “GABA-mimetics” (activating the receptor even without GABA present), which is why their curve does not plateau.